November 2006 - Toshiba America Medical Systems, Inc. has announced a new partnership with CVCTA Education and San ...
In its third quarter financial report, San Diego-based Cytori said it has moved significantly closer to initiating its cardiovascular clinical trials," said Christopher J. Calhoun, chief executive officer of Cytori Therapeutics. The company is developing adipose stem cells in cardiovascular disease and for use in reconstructive surgery.
Houston based ThromboVision, Inc. has won the first annual Michael E. DeBakey Life Science Award, which carries a $50,000 cash prize to assist in propelling the company's technology toward commercial success.
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
The stent market will have a distinctly different look after Johnson & Johnson completes its acquisition of Conor ...
A German physician reports that people who have implanted pacemakers or defibrillators are not in danger of their ...
The integration of Volcano’s intravascular ultrasound imaging (IVUS) capabilities into GE Healthcare’s Innova all ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Photos of medical images produced from a new 3-D volume rendering software have the appearance of something from a “Star ...
Siemens Medical Solutions’ ACUSON Antares ultrasound system, premium edition, features shared service cardiology ...
Cordis Corp. has received approval from the FDA to market its PRECISE Nitinol Stent and ANGIOGUARD Emboli Capture guide ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
ZOLL Medical Corp. has announced it is now shipping all models of the ZOLL M Series defibrillator that comply with 2005 ...
What doesn’t kill us, so the saying goes, makes us stronger. Those of us lucky enough to walk away from tragedy with our ...
Designed to speed cardiovascular workflow and help enhance patient care, the Xcelera R2.1 integrates examination results from key cardiology subspecialties, including interventional cardiology, cardiovascular ultrasound, ECG, nuclear cardiology, cardiac CT, cardiac MR and electrophysiology.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Training physicians, especially cardiac specialists, has taken on an increasingly critical role. With more cardiologists, cardiovascular surgeons and vascular surgeons interpreting CT data, the need for proper training has increased exponentially in recent years.
A guide wire-based occlusion device, the GuardDOG by Possis Medical enables physicians to quickly and effectively manage local blood flow while employing interventional techniques and devices to treat vascular disease. It features a 0.035-inch diameter guide wire, preferred for peripheral interventions, and a soft, compliant, CO2-filled balloon providing quick inflation and deflation.
The tiny tools of interventional cardiology known as drug-eluting stents (which happen to comprise a gargantuan U.S ...
November 20, 2006
